Food and Drug Administration import alerts affecting the following have been modified in the past week.
- antibiotics from China
- candy from China and Jordan
- mushrooms from China
- nonalcoholic beverages from the United Kingdom
- pistachios from Jordan
- rock lobster from Brazil
- sesame seed from India and Turkey
- soymilk biscuits from China
- spices and seasonings from Bangladesh
- sweet goods without custard or cream filling from India
- tilapia from Costa Rica
- tuna from Indonesia
- vegetable protein products for animal or human food use from China
- yogurt ice pops from China
Importers of FDA-regulated goods are responsible for ensuring that such imports are in compliance with FDA laws and regulations. Before shipping into the U.S., importers should be aware of whether or not their product is listed on an import alert.
Import alerts inform FDA field staff that the agency has enough evidence or other information to allow a product that appears to be in violation of FDA laws and regulations to be detained without physical examination at the time of entry. Import alerts may cover products from designated countries or areas (including from all foreign countries), manufacturers, or shippers.
Firms and/or products on the “red list” of an import alert are subject to DWPE, while firms and/or products on the “green list” are not because they have met the criteria for exclusion. Some import alerts include a “yellow list” of firms, products, and/or countries subject to intensified surveillance because the nature of the violations may warrant further field examinations of individual entries and/or additional analyses. In addition, depending on the specific import alert, shipments of products subject to DWPE may still be imported into the U.S. if the importer has demonstrated that the shipment is in compliance.
If a product is detained without physical examination the importer has the right to provide evidence to the FDA in an attempt to overcome the appearance of the violation. If no such evidence is submitted, or if the evidence provided is insufficient, the product will be subject to refusal of entry into the U.S.
For more information on this and other FDA issues, please contact Domenic Veneziano at (202) 734-3939.
Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.